AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16340950 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron plus iodine (190 mg iodine + 300 mg ferrous sulphate 5 times/week, n=24)
Number of subjects: 103
Study 16340950 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron (300 mg ferrous sulphate 5 times/week, n=23)
Number of subjects: 103
Study 16340950 — intervention group
Group type: COMPARATOR
Intervention: Iodine (190 mg iodine, n=25)
Number of subjects: 103
Study 16340950 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=22)
Number of subjects: 103
Study 14760043 — intervention group
Group type: EXPERIMENTAL
Intervention: Short standardized follow-up telephone call 1 week later
Number of subjects: 399
Study 14760043 — intervention group
Group type: COMPARATOR
Intervention: Standard intervention (no telephone call)
Number of subjects: 399
Study 10693639 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostacyclin (PGI2) 4 ng/kg per min for 6 days
Number of subjects: 30
Study 10693639 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 9121326 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin plus ofloxacin administered daily for 4 weeks
Number of subjects: 125
Study 8457524 — intervention group
Group type: EXPERIMENTAL
Intervention: Palm oil diet
Number of subjects: 38
Study 8457524 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 38
Study 3721646 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmon calcitonin 100 IU i.m. daily for 30 days
Number of subjects: 22
Study 3721646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 30138966 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin (20 μg/ml for 30 minutes)
Number of subjects: 0
Study 30427152 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease of body temperature (till 35.9 °C)
Number of subjects: 0
Study 30427152 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease of pH of venous blood (till 7.19)
Number of subjects: 0
Study 30427152 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease of ionized calcium content (till 0.32 mmole/l) in venous blood
Number of subjects: 0
Study 30427152 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase of lactate content (up to 4.1 mmole/l) in venous blood
Number of subjects: 0
Study 30427152 — intervention group
Group type: EXPERIMENTAL
Intervention: Rise of activated partial thromboplastin time (up to 59 sec)
Number of subjects: 0
Study 24415567 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg/d
Number of subjects: 161
Study 24415567 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg/d
Number of subjects: 161
Study 24415567 — intervention group
Group type: COMPARATOR
Intervention: Historical control (pseudo‐placebo monotherapy)
Number of subjects: 161
Study 22762977 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural anesthesia (CSE)
Number of subjects: 50
Study 22762977 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 50
Study 20042202 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin therapy
Number of subjects: 320
Study 20042202 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 320
Study 18354140 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic acromioplasty with mini-open rotator cuff repair (scope mini-open)
Number of subjects: 0
Study 18354140 — intervention group
Group type: COMPARATOR
Intervention: Open surgical repair
Number of subjects: 0
Study 15842269 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronally positioned flap alone (20 sites)
Number of subjects: 20
Study 15842269 — intervention group
Group type: COMPARATOR
Intervention: Coronally positioned flap with biodegradable membrane (20 sites)
Number of subjects: 20
Study 12215986 — intervention group
Group type: EXPERIMENTAL
Intervention: Genioplasty
Number of subjects: 127
Study 12215986 — intervention group
Group type: EXPERIMENTAL
Intervention: Large advancements (>7 mm)
Number of subjects: 127
Study 12215986 — intervention group
Group type: EXPERIMENTAL
Intervention: Small advancements (≤7 mm)
Number of subjects: 127
Study 12215986 — intervention group
Group type: COMPARATOR
Intervention: No genioplasty
Number of subjects: 127
Study 12215986 — intervention group
Group type: EXPERIMENTAL
Intervention: Age (older subjects)
Number of subjects: 127
Study 10512342 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric kinetic chain exercise for 12 weeks
Number of subjects: 26
Study 7853417 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide-based regimen with chest radiotherapy (n = 47)
Number of subjects: 262
Study 7853417 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide-based regimen without chest radiotherapy (n = 46)
Number of subjects: 262
Study 7853417 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide and cisplatin plus twice-daily chest radiotherapy (n = 54)
Number of subjects: 262
Study 7853417 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose etoposide plus cisplatin (n = 46)
Number of subjects: 262
Study 7853417 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose etoposide plus cisplatin (n = 44)
Number of subjects: 262
Study 7853417 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose etoposide plus cisplatin for poor-risk patients (n = 25)
Number of subjects: 262
Study 7853417 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival evaluation based on BMI levels
Number of subjects: 262
Study 1960557 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin 60 mg/m2
Number of subjects: 141
Study 1960557 — intervention group
Group type: COMPARATOR
Intervention: Epirubicin 90 mg/m2
Number of subjects: 141
Study 1960557 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Number of subjects: 141
Study 1960557 — intervention group
Group type: COMPARATOR
Intervention: Epirubicin
Number of subjects: 141
Study 6758456 — intervention group
Group type: EXPERIMENTAL
Intervention: TEA for 24 hours
Number of subjects: 98
Study 6758456 — intervention group
Group type: EXPERIMENTAL
Intervention: TEA plus general anesthesia with IPPV
Number of subjects: 98
Study 6758456 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia with IPPV but no TEA
Number of subjects: 98
Study 31162017 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline 200 mg/day for 6 weeks
Number of subjects: 202
Study 31162017 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment (6 months deferred)
Number of subjects: 202
Study 31162017 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline treatment
Number of subjects: 202
Study 29186908 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein and high fiber diet (HPHFib)
Number of subjects: 89
Study 29186908 — intervention group
Group type: COMPARATOR
Intervention: Standard diet (StdD)
Number of subjects: 89
Study 26552032 — intervention group
Group type: EXPERIMENTAL
Intervention: Stochastic leader gravitational search algorithm (SL‐GSA)
Number of subjects: 0
Study 26552032 — intervention group
Group type: COMPARATOR
Intervention: Standard GSA (SGSA)
Number of subjects: 0
Study 23924263 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive arms (web access to facilitator training materials and toolkits without technical assistance)
Number of subjects: 7200
Study 23924263 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive arms (web access to facilitator training materials and toolkits with technical assistance)
Number of subjects: 7200
Study 23924263 — intervention group
Group type: EXPERIMENTAL
Intervention: Active arms (in-person access to facilitator training materials and toolkits without technical assistance)
Number of subjects: 7200
Study 23924263 — intervention group
Group type: EXPERIMENTAL
Intervention: Active arms (in-person access to facilitator training materials and toolkits with technical assistance)
Number of subjects: 7200
Study 23924263 — intervention group
Group type: COMPARATOR
Intervention: N/A (control group not explicitly mentioned)
Number of subjects: 7200
Study 21574777 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (20 g·day(‐1) for 1 week and 5 g·day(‐1) thereafter)
Number of subjects: 50
Study 21574777 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 19292064 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX/Isoniazid (INH)
Number of subjects: 201
Study 19292064 — intervention group
Group type: COMPARATOR
Intervention: MTX alone
Number of subjects: 201
Study 17000348 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological factors (arousal and valence)
Number of subjects: 525
Study 15577627 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural intervention activities (attendance at meetings, videos, dramas, interactions with community educators)
Number of subjects: 3394
Study 15577627 — intervention group
Group type: COMPARATOR
Intervention: No intervention (comparison communities)
Number of subjects: 3394
Study 11378339 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (doxorubicin 50 mg/m² i.v. bolus and ifosfamide 5 g/m² 24 h infusion)
Number of subjects: 134
Study 11378339 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 134
Study 11378339 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (doxorubicin and ifosfamide)
Number of subjects: 134
Study 9294274 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic laparoscopy
Number of subjects: 161
Study 9294274 — intervention group
Group type: COMPARATOR
Intervention: Control group (no laparoscopy)
Number of subjects: 161
Study 9294274 — intervention group
Group type: COMPARATOR
Intervention: Postmenopausal women
Number of subjects: 161
Study 9294274 — intervention group
Group type: COMPARATOR
Intervention: Male adults
Number of subjects: 161
Study 8357473 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual specific immunotherapy with purified and standardised allergen (Stallergenes '5-grass pollen')
Number of subjects: 58
Study 8357473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 3511392 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg 5 X in 30 h)
Number of subjects: 10
Study 3511392 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31884895 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Hygiene Protocol (SHP)
Number of subjects: 22
Study 31884895 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 22
Study 29982277 — intervention group
Group type: COMPARATOR
Intervention: Casein protein-based (CP) meals
Number of subjects: 37
Study 29982277 — intervention group
Group type: EXPERIMENTAL
Intervention: Pea protein-based (PP) meals
Number of subjects: 37
Study 29982277 — intervention group
Group type: COMPARATOR
Intervention: CP meals
Number of subjects: 37
Study 29982277 — intervention group
Group type: EXPERIMENTAL
Intervention: PP meals
Number of subjects: 37
Study 27788184 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised Illness Perception Questionnaire (IPQ‐R)
Number of subjects: 0
Study 27788184 — intervention group
Group type: EXPERIMENTAL
Intervention: Psoriasis Life Stress Inventory (PLSI)
Number of subjects: 0
Study 27788184 — intervention group
Group type: EXPERIMENTAL
Intervention: WHOQOL‐Physical
Number of subjects: 0
Study 27788184 — intervention group
Group type: EXPERIMENTAL
Intervention: WHOQOL‐Psychological
Number of subjects: 0
Study 27788184 — intervention group
Group type: EXPERIMENTAL
Intervention: WHOQOL‐Social
Number of subjects: 0
Study 27788184 — intervention group
Group type: EXPERIMENTAL
Intervention: WHOQOL‐Environmental
Number of subjects: 0
Study 27788184 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between emotional representations associated with ZCL and loss of self-esteem
Number of subjects: 0
Study 27788184 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between education level and cognitive/emotional representation in IPQ‐R
Number of subjects: 0
Study 27788184 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between rejection experiences and age
Number of subjects: 0
Study 27788184 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between anticipation and avoidance of stress and age
Number of subjects: 0
Study 27788184 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between perceived quality of social life and knowledge about ZCL
Number of subjects: 0
Study 23579066 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial, individualized 12-month falls prevention programme
Number of subjects: 1314
Study 22837545 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic physical conditioning with moderate intensity
Number of subjects: 42
Study 22837545 — intervention group
Group type: COMPARATOR
Intervention: Daily life activities (Control)
Number of subjects: 42
Study 20484474 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH+Arg test
Number of subjects: 69
Study 20484474 — intervention group
Group type: COMPARATOR
Intervention: ITT test
Number of subjects: 69
Study 18492001 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise program (3 times a week for 8 weeks)
Number of subjects: 32
Study 16163677 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised questionnaire after initial comments from first three groups
Number of subjects: 31
Study 16163677 — intervention group
Group type: COMPARATOR
Intervention: Initial questionnaire before revisions
Number of subjects: 31
Study 12969045 — intervention group
Group type: EXPERIMENTAL
Intervention: OAA leaflet 'Pain Relief in Labour' (Intervention group)
Number of subjects: 76
Study 12969045 — intervention group
Group type: COMPARATOR
Intervention: Standard booking information (Control group)
Number of subjects: 76
Study 11130159 — intervention group
Group type: EXPERIMENTAL
Intervention: Michigan Alcoholism Screening Test (MAST)
Number of subjects: 135
Study 11130159 — intervention group
Group type: EXPERIMENTAL
Intervention: CAGE
Number of subjects: 135
Study 8806373 — intervention group
Group type: EXPERIMENTAL
Intervention: Bathers exposed to fecal streptococci
Number of subjects: 1273
Study 8806373 — intervention group
Group type: EXPERIMENTAL
Intervention: Bathers exposed to fecal coliform
Number of subjects: 1273
Study 8806373 — intervention group
Group type: EXPERIMENTAL
Intervention: Bathers
Number of subjects: 1273
Study 8806373 — intervention group
Group type: COMPARATOR
Intervention: Nonbathers
Number of subjects: 1273
Study 1628583 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Relaxation Training (PRT, n = 13)
Number of subjects: 24
Study 1628583 — intervention group
Group type: COMPARATOR
Intervention: Quiet Sitting (QS, n = 11)
Number of subjects: 24
Study 6480200 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric exercise
Number of subjects: 8
Study 6480200 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 8
Study 31527899 — intervention group
Group type: EXPERIMENTAL
Intervention: artesunate‐amodiaquine (ASAQ)
Number of subjects: 865
Study 31527899 — intervention group
Group type: EXPERIMENTAL
Intervention: artemether‐lumefantrine (AL)
Number of subjects: 865
Study 31527899 — intervention group
Group type: EXPERIMENTAL
Intervention: quinine+clindamycin (QnC)
Number of subjects: 865
Study 31527899 — intervention group
Group type: EXPERIMENTAL
Intervention: postRCT1
Number of subjects: 865
Study 31527899 — intervention group
Group type: EXPERIMENTAL
Intervention: postRCT2
Number of subjects: 865
Study 31527899 — intervention group
Group type: EXPERIMENTAL
Intervention: postRCT3
Number of subjects: 865
Study 31527899 — intervention group
Group type: EXPERIMENTAL
Intervention: preRCT
Number of subjects: 865
Study 29540336 — intervention group
Group type: EXPERIMENTAL
Intervention: Ilaparazole 10 mg QD
Number of subjects: 537
Study 29540336 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole 40 mg QD
Number of subjects: 537
Study 27041672 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC-Docetaxel (FEC-D)
Number of subjects: 66
Study 27041672 — intervention group
Group type: COMPARATOR
Intervention: TCx6 (TC6)
Number of subjects: 66
Study 25005651 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative antibiotic treatment with amoxicillin plus clavulanic acid (2 g, 3 times a day for 5 days)
Number of subjects: 414
Study 25005651 — intervention group
Group type: COMPARATOR
Intervention: No postoperative antibiotics (nontreatment group)
Number of subjects: 414
Study 25005651 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (antibiotic and nontreatment)
Number of subjects: 414
Study 22681960 — intervention group
Group type: COMPARATOR
Intervention: Intravenous esomeprazole
Number of subjects: 100
Study 22681960 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral lansoprazole
Number of subjects: 100
Study 20929937 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial suture placement in torn tendons
Number of subjects: 0
Study 20929937 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral suture placement in intact tendons
Number of subjects: 0
Study 20929937 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral suture placement in torn tendons
Number of subjects: 0
Study 20929937 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial suture placement in intact and torn tendons
Number of subjects: 0
Study 20929937 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral region in torn specimens
Number of subjects: 0
Study 20929937 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral region in intact specimens
Number of subjects: 0
Study 17974932 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management cognitive behavior therapy
Number of subjects: 45
Study 17974932 — intervention group
Group type: COMPARATOR
Intervention: Supportive counseling
Number of subjects: 45
Study 16387596 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab (0.016 mg/kg/IgE [IU/mL]/mo) plus immunotherapy
Number of subjects: 159
Study 16387596 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab plus immunotherapy
Number of subjects: 159
Study 16387596 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus immunotherapy
Number of subjects: 159
Study 11891449 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral laminectomy
Number of subjects: 0
Study 11891449 — intervention group
Group type: COMPARATOR
Intervention: Conservative therapy
Number of subjects: 0
Study 9860243 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin application food test (SAFT)
Number of subjects: 0
Study 8106625 — intervention group
Group type: EXPERIMENTAL
Intervention: RU 486 (200 mg/day)
Number of subjects: 10
Study 8106625 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2802540 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine
Number of subjects: 8
Study 2802540 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31061282 — intervention group
Group type: EXPERIMENTAL
Intervention: Na restriction (NaCl: 6 g/d)
Number of subjects: 11
Study 31061282 — intervention group
Group type: COMPARATOR
Intervention: Control (NaCl: 12 g/d)
Number of subjects: 11
Study 28676251 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral contraceptives (COC)
Number of subjects: 0
Study 28676251 — intervention group
Group type: COMPARATOR
Intervention: Free cycling women
Number of subjects: 0
Study 25403027 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally sensitive empowerment group intervention (Nia)
Number of subjects: 89
Study 25403027 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 89
Study 23912197 — intervention group
Group type: COMPARATOR
Intervention: Dry needling
Number of subjects: 28
Study 23912197 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling combined with autologous conditioned plasma (ACP) injection
Number of subjects: 28
Study 21838845 — intervention group
Group type: EXPERIMENTAL
Intervention: CRA plus vouchers
Number of subjects: 58
Study 21838845 — intervention group
Group type: COMPARATOR
Intervention: CRA
Number of subjects: 58
Study 19663128 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified extract VIT (group A, 44 patients)
Number of subjects: 94
Study 19663128 — intervention group
Group type: COMPARATOR
Intervention: Nonpurified extract VIT (group B, 50 patients)
Number of subjects: 94
Study 16455438 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand moxibustion
Number of subjects: 10
Study 16455438 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand acupuncture
Number of subjects: 10
Study 16455438 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 10
Study 15181138 — intervention group
Group type: EXPERIMENTAL
Intervention: Shifting emission images after initial scans
Number of subjects: 1177
Study 15181138 — intervention group
Group type: COMPARATOR
Intervention: Initial MAC scan followed by emission scans
Number of subjects: 1177
Study 15181138 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragm displacement measurement
Number of subjects: 1177
Study 15181138 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative misregistration assessment
Number of subjects: 1177
Study 12078910 — intervention group
Group type: EXPERIMENTAL
Intervention: Early complete response (ECR) patients after initial cycles of chemotherapy
Number of subjects: 0
Study 12078910 — intervention group
Group type: COMPARATOR
Intervention: Shortened treatment in ECR patients (randomized Swedish trial)
Number of subjects: 0
Study 12078910 — intervention group
Group type: COMPARATOR
Intervention: ECR patients receiving only six cycles (EORTC 20884 study)
Number of subjects: 0
Study 12078910 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthracyclines plus alkylating agents in children who failed to reach ECR (French MDH 90 trial)
Number of subjects: 0
Study 12078910 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved field radiotherapy for patients who failed to reach ECR (EORTC 20884 study)
Number of subjects: 0
Study 9621488 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin (100 mg/m2 at 7 and 21 days) with 148 MBq 89Sr
Number of subjects: 30
Study 9621488 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (50 mg/m2 in two administrations) with 148 MBq 89Sr
Number of subjects: 30
Study 9621488 — intervention group
Group type: COMPARATOR
Intervention: 89Sr alone
Number of subjects: 30
Study 9621488 — intervention group
Group type: COMPARATOR
Intervention: 89Sr + placebo
Number of subjects: 30
Study 8576718 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompting device available (experimental group)
Number of subjects: 39
Study 8576718 — intervention group
Group type: COMPARATOR
Intervention: No prompting device available (control group)
Number of subjects: 39